FoRx Therapeutics
Basel
About FoRx Therapeutics
FoRx Therapeutics is a recently incorporated privately-held company aiming to develop first-in-class compounds for cancer treatment. FoRx focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $109.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: forxtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/forx-therapeutics-80326 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.